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Abstract

Cognitive failures are errors in normal everyday functioning. Individuals with psychological disorders may
possess heightened vulnerability. We sought to review the literature on cognitive failures in psychological
disorders to determine the nature of this association, and whether failures relate to neuropsychological
performance. We also examine the relationship between cognitive failures and substance use since it is
relevant to everyday cognition and co-occurs in many psychological disorders. Methods: We conducted a
systematic review of self-reported cognitive failures in psychological disorders and substance use, identifying
21 papers in total. Results: Papers identified studied trauma, mood, and anxiety disorders, and schizophrenia.
Substance use papers included nicotine, alcohol, cannabis, and ecstasy use. Cognitive failures were increased
in some but not all papers; the most consistent findings were for depression, PTSD, and daily smokers of
nicotine. Subjective failures did not correlate closely with neuropsychological outcomes in any disorders. We
were unable to discern distinct profiles of failures for each disorder; rather they may reflect emotional
dysregulation more broadly. Conclusions: The real world cognitive experiences of people with psychological
disorders may differ to their performance in the clinic or lab. It is important that self-reports of minor
cognitive issues are considered as both a potential risk and a maintaining factor of illness. Substance use also
needs to be considered in assessing cognitive failures.
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Abstract:
Introduction: Cognitive failures are errors in normal everyday functioning.
Individuals with psychological disorders may possess heightened vulnerability. We
sought to review the literature on cognitive failures in psychological disorders to
determine the nature of this association, and whether failures relate to
neuropsychological performance. We also examine the relationship between
cognitive failures and substance use since it is relevant to everyday cognition and cooccurs in many psychological disorders.
Methods: We conducted a systematic review of self-reported cognitive failures in
psychological disorders and substance use, identifying 21 articles in total.
Results: Articles identified studied trauma, mood, and anxiety disorders, and
schizophrenia. Substance use articles included nicotine, alcohol, cannabis, and
ecstasy use. Cognitive failures were increased in some but not all papers; the most
consistent findings were for depression, PTSD, and daily smokers of nicotine.
Subjective failures did not correlate closely with neuropsychological outcomes in
any disorders. We were unable to discern distinct profiles of failures for each
disorder; rather they may reflect emotional dysregulation more broadly.
Conclusions: The real world cognitive experiences of people with psychological
disorders may differ to their performance in the clinic or lab. It is important that selfreports of minor cognitive issues are considered as both a potential risk and a
maintaining factor of illness. Substance use also needs to be considered in assessing
cognitive failures.
Keywords: Cognitive failures; subjective cognition; psychological disorders; mental
health; substance use.
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A systematic review of the relationship between psychological disorders or substance use
and self-reported cognitive failures.
Introduction
As people go about their daily lives, most experience the irritating phenomenon of cognitive
failures – also known as cognitive slips or “brain farts.” Common failures include finding
yourself re-reading the same page of a book multiple times, or putting salt instead of sugar on
your cereal. As these examples illustrate, cognitive failures occur during routine tasks that one
would usually have no difficulty in successfully completing (Clark, Parakh, Smilek, & Roy,
2011). As such, they represent a lapse in cognition in “real world” settings, rather than an ability
deficit (Broadbent, Cooper, FitzGerald, & Parkes, 1982).
Cognitive failures are experienced by everyone from time to time, and are normally distributed
throughout the general population (Boomsma, 1998; Kanai, Dong, Bahrami, & Rees, 2011).
Some people are more prone to making errors than others; of interest are the factors that
determine this vulnerability. Objective cognition largely captures (relatively) stable ability,
whilst cognitive failures are thought to reflect capacity: where performance might shift
depending on context (Carrigan & Barkus, 2016). Cognitive failures are shaped by trait-based
vulnerability factors related to personality (e.g. Bruce et al., 2007; Pfeifer, van Os, Hanssen,
Delespaul, & Krabbendam, 2009), but also appear to be shaped by fluctuating state factors
including mood and stress (Ishigami & Klein, 2009), wakefulness (Wallace, Vodanovich, &
Restino, 2003), and even time of day (Mecacci, Righi, & Rocchetti, 2004).
In addition to these contributing factors, people suffering from psychological disorders are also
thought to be more vulnerable to cognitive failures (Broadbent et al., 1982; Merckelbach, Muris,
4
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Nijman, & de Jong, 1996). However, there has been an emphasis on traditional objective
measures of cognition in both healthy and clinical populations, meaning knowledge around
everyday cognitive functioning in psychological disorders is limited. This in turn places
limitations on conceptualisation and treatment of patients’ cognitive difficulties. For example, in
schizophrenia, up to 27% of patients exhibit normal neuropsychological functioning on objective
assessments (Palmer et al., 1997), despite severe impairment in daily life. If clinicians refer
primarily to test performance, they are unlikely to comprehend the breadth of disruption to the
real world functioning of their patients, and will thus be limited in their ability to provide
effective treatment. There is therefore a need to improve our understanding of subjective
experiences of cognition in patients’ daily lives. This review will serve to form a preliminary
picture of the association between cognitive failures and different psychological disorders.
Measurement of cognitive failures
There are a number of approaches utilised in measuring cognitive failures. Several experimental
tasks have been designed to capture aspects of cognition essential to everyday life. For example,
the Sustained Attention to Response Task (SART; Robertson, Manly, Andrade, Baddeley, &
Yiend, 1997) assesses susceptibility to everyday attention failures, whilst tip-of-the-tongue
studies examine proneness to word retrieval failures (Maylor, 1990). Recently more naturalistic
measures have been applied, such as testing prospective memory by instructing participants to
call at a prescribed time in the future (Cuttler, Graf, Pawluski, & Galea, 2011). Alongside such
tasks, there has also been increasing interest in self-reported perceptions of everyday slips and
failures; this will be the focus of the current article. Several self-report tools have been
developed, with the most widely used being the Cognitive Failures Questionnaire (CFQ;
Broadbent et al., 1982). The CFQ requires individuals to indicate how frequently they have
5
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experienced a list of minor perceptual, memory, and action failures in everyday life; higher
scores reflect a general vulnerability to slips. Interestingly, correlations with the CFQ have been
used to confirm the ecological validity of objective measures of everyday cognition, including
the SART (Smilek, Carriere, & Cheyne, 2010a).
However, the use of self-reported cognitive failures leads to questions of validity. Given that
neuropsychological assessments are considered the “gold-standard” method of capturing
cognition, the poor correspondence between performance on neuropsychological assessments
and self-reported slips is of concern to some authors (Donohoe et al., 2009; Wilhelm, Witthoeft,
& Schipolowski, 2010). It may be, however, that the two types of assessment are capturing
different, but equally relevant and valid, aspects of cognition.
The reliability of self-reported cognitive failures is also questioned. Particularly pertinent is the
association between cognitive failures and neuroticism (Broadbent et al., 1982; Gerald Matthews
& Wells, 1988). Two views of this relationship are expressed: neurotic people, 1) are genuinely
more prone to everyday cognitive failures (Neupert, Mroczek, & Spiro, 2008; Suls & Martin,
2005), or 2) tend to exaggerate reports of failures due to their negative self-appraisal style
(Wilhelm, Witthöft, & Schipolowski, 2010). It is necessary to determine more imaginative
methods for validating the assessment of cognitive failures to ensure that the concerns of critics
can be addressed.
Certainly, the use of informants in cognitive failures could help to address concerns over both the
validity and reliability of cognitive failures. Given the behavioural nature of many of the
complaints captured under the banner of cognitive failures, it is possible that those living with
one another could be aware of the extent to which they are experienced. Across the healthy

6

COGNITIVE FAILURES, PSYCHOLOGICAL DISORDERS, SUBSTANCE USE
population, self-reported cognitive failures show moderate correlations with informant ratings
(Broadbent et al., 1982; Mahoney, Dalby, & King, 1998), as well as with real world outcomes
such as the likelihood of being at-fault in a car accident (Larson & Merritt, 1991). This suggests
that self-reported cognitive failures are indeed of value as an indication of proneness to problems
with real world cognition. Further studies are needed corresponding both subjective and
informant ratings of cognitive failures to assist in addressing some of the measurement concerns;
other creative methods such as real time assessment may also be of use.
Cognitive failures in psychological disorders and substance use
Feeling overwhelmed with the demands of life tends to go hand-in-hand with difficulty thinking
clearly. Cognitive failures are known to be associated with stress (Mahoney et al., 1998) and
negative affect (Payne & Schnapp, 2014), and patients with a range of psychological disorders
including depression, bipolar, generalised anxiety, and schizophrenia complain of similar
difficulties (American Psychiatric Association, 2013). The link between these disorders and
objective cognitive outcomes has been well covered (e.g. David, Zammit, Lewis, Dalman, &
Allebeck, 2008), however investigation of patients’ experiences of everyday slips has been
limited. There are two key possibilities for the nature of a relationship between psychopathology
and cognitive failures: 1) problems with cognitive functioning in everyday life causally
contribute to aspects of illness such as negative affect (e.g. Carriere, Cheyne, & Smilek, 2008),
or 2) vulnerable individuals’ already compromised systems struggle to cope with daily stressors,
resulting in cognitive failures (e.g.Matthews, Coyle, & Craig, 1990). It is beyond the scope of
this paper to elucidate how cognitive failures and psychological disorders influence each other;
however, a review of the currently disparate literature will provide information about which
particular disorders are most affected.
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This review will also consider the effects of substance use on cognitive failures. This is of
interest for a number of reasons. First, there is already a large body of research that has
demonstrated the impact substance use has on everyday cognition. For example, ability to
successfully carry out cognition necessary for safe driving is adversely impacted by use of
substances including alcohol (Marczinski, Harrison, & Fillmore, 2008) and cannabis (Downey et
al., 2013). Whilst these findings are based on objective measures of cognition (i.e. driving
simulators), they suggest that real world cognition – as in cognitive failures - may also be
affected by substance use.
Second, there is an overlap between psychological disorders and substance use. A high
proportion of individuals with a psychiatric diagnosis will either have co-morbid substance use
disorders, or use substances including nicotine, alcohol, and illicit drugs (Weaver et al., 2003). In
those studies that do measure cognitive failures in clinically-defined populations there tends to
be a lack of consideration for the potential role of substance use, most likely due to the
complexity of clinical presentations. Therefore it is important to consider any findings for the
effects of substance use on cognitive failures, even those studies considering substance use in
otherwise psychologically healthy individuals would provide useful information.
Objectives of the current review
There have been a number of studies examining cognitive failures in individuals with
psychological disorders and in substance use, however their findings are yet to be drawn
together. This review will seek to determine whether or not there is a relationship between
cognitive failures and different psychological disorders or substance use, and how this relates to
objective cognitive outcomes. Specifically, three core questions will be explored:
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1) What is the relationship between cognitive failures and psychological disorders?
2) What is the relationship between cognitive failures and substance use?
3) How do subjective cognitive failures relate to performance on objective tasks in people
with psychological disorders or in substance users?
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Method
We designed and reported this systematic review based on the PRISMA (Preferred Reporting
Items for Systematic reviews and Meta-Analyses) statement, an internationally recognised 27item method ensuring the highest standard in systematic reviewing (Liberati et al., 2009).
PRISMA was developed as an update to previous standards provided by the QUOROM (Quality
Of Reporting Of Meta-analyses) statement, and is based on the definitions of systematic reviews
and meta-analyses set forth by the Cochrane Collaboration.
Search strategy
Studies were identified by searching electronic databases and scanning reference lists. PsycINFO
(1967-March 2016), Web of Science’s Social Sciences Citation Index (1956-March 2016),
Scopus (1960- March 2016) and the Cochrane database were searched using the following index
items via Boolean search criteria: “cognitive failure* OR cognitive slip* OR subjective cogniti*
AND everyday;” “cognitive slip* OR cognitive failure* OR subjective cogniti* AND daily.”
These search terms were derived from examination of seminal cognitive failure articles (e.g.
Broadbent et al., 1982; Wallace, Kass, & Stanny, 2002). Several other search terms were
considered but ultimately excluded.
Whilst “mind-wandering” is sometimes used interchangeably with cognitive failures, it refers to
a phenomenon that may result in failures in thought or action, rather than errors themselves. In
addition, preliminary searches found that the majority of recent papers focus on mindfulness or
the content of daydreams, rather than errors that may arise. “Accident-proneness” is another
term that has previously been associated with cognitive failures (e.g. Reason, 1979), however
this is now largely confined to human factors research where it refers to a concept encapsulating
10
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issues beyond human errors in cognition. The chosen search terms therefore reflect the current
review’s focus on cognitive failures, defined as cognitive capacity in everyday life which is fluid
and may fluctuate according to shifts in factors such as illness and environment (Carrigan &
Barkus, 2016).
No limits were applied for year of publication or language, and translated foreign papers were
accessed. Reference lists of key articles were hand-searched. All types of studies apart from case
studies and theoretical papers were included in the search. The last search was run on 15th
March, 2016.
Eligibility criteria
Inclusion and exclusion criteria were postulated prior to the search. Studies were included
if they were:


Published in a refereed journal;



Identified cognitive failures or subjective cognitive complaints as one of their primary
measures or outcomes;



Sampled from populations with any psychological disorder listed in the Diagnostic and
Statistical Manual, including substance use disorders; OR



Sampled from healthy populations but examined substance use including that of alcohol
and other drugs, but excluding caffeine; and



Utilised the CFQ as a subjective measure of everyday cognitive performance.

Studies were excluded if they:
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Sampled from a non-psychologically disordered population, including those with
neurological disorders such as dementia or traumatic brain injury, or those with other
cognitive disorders such as dyslexia;



Were attempts to validate the CFQ with specific populations (e.g. cultural, language
groups) or created for specific populations (e.g. elderly people);



Came from non-psychological or health-related research fields (e.g. ergonomics); or



Studied outcomes of a new intervention.

This search strategy focused on the CFQ, excluding objective, laboratory-based measures such as
the SART. This enabled an exploration of everyday cognitive functioning, with self-reported
failures capturing real world errors that cannot be replicated in the lab. It should also be noted
that there are a number of other self-report tools available including the Attention-Related
Cognitive Errors Scale (ARCES; Smilek, Carriere, & Cheyne, 2010b), Short Inventory of Minor
Lapses (SIML; Reason, 1993), and the Prospective and Retrospective Memory Failures
Questionnaire (PRMQ; Smith, Della Sala, Logie, & Maylor, 2000). However, preliminary
searches failed to identify a substantial number of articles that utilised these measures with
clinical populations. In addition, the CFQ is one of the broadest measures, covering slips in
memory, attention, and perception. Therefore, a sole focus on the CFQ was chosen to ensure
consistency and clarity.
This review was left open to clinical populations with any kind of psychological disorder as
listed in the DSM 5, excluding those defined by neurological issues or severe cognitive
impairment, such as dementia, learning disorders, and ADHD. Given the field of cognitive
failures is still relatively small, this relatively open search approach was taken as a means of
providing a preliminary overview of the literature, as per the aims of this review.
12
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Case studies, letters to the editor, and conference abstracts were excluded. The researchers
screened titles and abstracts of the articles gathered during the search against the exclusion
criteria. Selected articles were then read and excluded if they did not meet criteria.
INSERT FIGURE 1 ABOUT HERE
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Results
We included 21 articles in the review. The studies varied widely in their research design and
grouping of participants. Almost all of the studies used correlational designs (n =19), with some
longitudinal studies (n = 2; Manning, Teo, Guo, Wong, & Li, 2016; van den Bosch, Rombouts,
& van Asma, 1993).
Study characteristics
Location
The largest portion of articles came from the United Kingdom (n =8), these were largely studies
looking at substance use. The United States contributed the next largest portion (n = 4), followed
by the Netherlands (n = 3), and Australia (n = 1), Bosnia-and-Herzegovina (n = 1) Canada (n =
1), the Czech Republic (n = 1), Ireland (n = 1), and Singapore (n = 1).
Study populations
We identified studies focusing on a range of different psychological disorders. Sampled
populations included those with:


Affective disorders, including major depressive and bipolar disorders.



Anxiety disorders.



Post-traumatic stress disorder.



Schizophrenia.

We identified papers sampling from users of the following substances:


Nicotine.
14
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Alcohol.



Cannabis, ecstasy, and polydrug use.

We examined the studies and arranged them into sub-tables according to the disorder or
substance they examined. Some articles contained overlapping topics; these were placed into
sub-tables based on their primary focus.
Whilst it was not the purpose of this paper to additionally conduct a meta-analysis, we calculated
effect sizes for each study that provided sufficient statistical detail. The majority of studies
identified for this review provided CFQ means and standard deviations, which enabled
calculation of standardised mean differences (Lipsey & Wilson, 2001). As such, d and 95%
confidence intervals were calculated for those studies that presented data on between-groups
differences in CFQ scores, and are presented in Tables 1, 2, and 3. A small number of studies
instead reported correlations between CFQ scores and those of diagnostic measures; in these
cases r correlation coefficients were transformed into d for ease of comparison (Borenstein,
Hedges, Higgins, & Rothstein, 2009). The size of these effects as per Cohen’s (1988) suggested
classifications are also indicated in the tables.
Relationship between psychological disorders and cognitive failures
Affective disorders
As per Table 1, four papers examined depression and consistently demonstrated a profile of
elevated cognitive failures (Farrin, Hull, Unwin, & Wykes, 2003; MacQueen, Galway, Hay,
Young, & Joffe, 2002; Preiss, Kramska, Dockalova, Holubova, & Kucerova, 2010; Sullivan &
Payne, 2007). Effect sizes for the differences between depressed and control individuals were
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generally large. In bipolar populations there were only two studies identified, neither of which
found any evidence of a relationship between the disorder and heightened cognitive failures.
INSERT TABLE 1 ABOUT HERE.
These studies mirror recent attempts to uncover a neuropsychological profile of depression.
These have so far identified central deficits in the objectively-measured domains of attention,
executive functioning, and to a lesser extent episodic memory (e.g. McDermott & Ebmeier,
2009; Rock, Roiser, Riedel, & Blackwell, 2014).
The presence of objective deficits in patients in remission supports cognitive impairment as a
core feature of depression, impacting psychosocial functioning independent of mood
fluctuations. Accordingly, patients whose mood responds positively to antidepressant treatment
continue to report heightened cognitive failures in everyday life (MacQueen et al., 2002). Farrin
et al. (2003) described a vicious cycle between depression and cognitive failures, whereby
normal errors trigger strong, negative reactions (thoughts, feelings) that drain cognitive
resources, further increasing the chance of errors. Similar levels of failures were noted in those
with seasonal affective disorder (Sullivan & Payne, 2007), suggesting that the failures may not
be specifically associated with any one subtype of depression.
However, two studies of individuals with bipolar disorder found that patients in various phases
of illness (depressed, hypomanic and euthymic) tended to report fewer failures relative to both
healthy controls (Schouws, Comijs, Stek, & Beekman, 2012) and their own objectively-assessed
neuropsychological deficits (Burdick, Endick, & Goldberg, 2005). This pattern of “underreporting” is difficult to interpret, as illness chronicity is linked to significant confounds such as
mood stabilising medications and the adjustment or lowering of perceptions/expectations of
16
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functioning over time. In addition, hypomanic symptoms may reduce awareness of errors made
in an everyday context.
Non-affective disorders
We identified only seven articles that focused on psychological disorders other than mood
disorders (Table 2). These included two examining anxiety disorders, three on trauma-related
disorders, and two on schizophrenia. The findings of these papers were less consistent than those
regarding depression. There appear to be weak links between increased cognitive failures and
anxiety (Grisham, Norberg, Williams, Certoma, & Kadib, 2010; Merckelbach et al., 1996), and
one of these papers found a comparatively stronger association with depression (Merckelbach et
al., 1996). The findings regarding schizophrenia were mixed, with one group identifying no
increase in failures for psychosis compared to controls (Donohoe et al., 2009), whilst the other
found a large difference, comparable to the heightened reports of those with major depression
(van den Bosch et al., 1993). The most robust findings related to trauma, with CFQ scores being
greatly increased in those with PTSD symptoms (Boals & Banks, 2012; Boals, 2008; Koso,
Sarač-Hadzihalilovic, & Hansen, 2012). More detailed information about these findings is
provided following Table 2.
INSERT TABLE 2 ABOUT HERE.
Anxiety disorders
Anxiety symptoms in a healthy student population were correlated positively with CFQ scores
(Merckelbach et al., 1996). However, in another sub-study the same authors found that clinically
anxious patients reported failures similar to controls, and less than depressed patients
(Merckelbach et al., 1996). Conversely, clinically anxious participants in the second identified
17
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anxiety article reported significantly more errors than controls, although there were no
differences between hoarding and non-hoarding patients (Grisham et al., 2010). It was somewhat
surprising that there were so few papers on failures and anxiety disorders, given the significant
impact anxiety can have on everyday functioning. There were also some limitations of the
identified papers; primarily, both of these studies featured a mixed sample rather than being
disorder-specific. Included were individuals with a range of anxiety disorders, such as panic
disorder, social phobia, and OCD, as well as those with co-morbid depression. Given the
heterogeneity of these disorders, the current review provides only a limited glimpse of the
potential link between anxiety and everyday cognition.
Post-traumatic stress disorder
Individuals with post-traumatic stress disorder (PTSD) are another group experiencing a high
frequency of cognitive failures (Boals & Banks, 2012; Boals, 2008), with symptom severity
related to both daily slips and neuropsychological deficits (Koso et al., 2012). Intrusive
memories surrounding trauma and “flashbacks” are thought to drain cognitive resources,
increasing the likelihood of slips (Boals, 2008). Importantly, situational stress appears to interact
with PTSD symptoms for an additive effect that can trigger even more failures (Boals & Banks,
2012).
Whilst the findings in these three articles were consistent, it is notable that they involved quite
different forms of PTSD. Boals and Banks’ study (2012) utilised a student population reporting
the experience of at least one traumatic lifetime event which led to clinical symptoms of PTSD.
Such events included a serious accident, or an unexpected death. The other studies, meanwhile,
included survivors of Holocaust concentration camps (Boals, 2008) and servicemen who were
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torture survivors from the Bosnian war (Koso et al., 2012). These prolonged experiences of pain
and harm would precipitate complex trauma, quite distinct to the one-off incidents faced by
students. Whilst the “brain-drain” caused by intrusive memories provides one explanation of
cognitive failures, complex trauma involves sequelae additional to PTSD, such as elevated
arousal systems, somatisation, dissociation, and high risk for repeated harm (Herman, 1992); all
of which may also impact cognition. Other factors of potential significance that have yet to be
considered are time since traumatic event (e.g. 20 years between Bosnian war and article
publication vs. 60 years between Holocaust and article publication), and presence of psychotic
symptoms.
Schizophrenia
Schizophrenia was another disorder for which no distinct profile of cognitive failures is yet
evident, with findings of both increased (van den Bosch et al., 1993) and normal levels (Donohoe
et al., 2009) of everyday problems.
These studies included two quite different groups: recently hospitalised patients versus “stable”
chronic patients. A possible explanation for the discrepancy in findings, therefore, is difference
in phase of illness. Chronic sufferers may develop compensatory strategies through their
experiences, and thus evidence fewer cognitive failures than younger individuals recovering
from their first psychotic episode. However, given the paucity of information on inclusion
criteria and sample characteristics in the current literature, further phase-specific research is
necessary before such conclusions can be drawn.
Broadly, positive psychotic symptoms were associated with failures whilst negative symptoms
were not (van den Bosch et al., 1993). Van den Bosch et al. (1993) suggest the complexity of
19
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sensory information in everyday life overloads compromised sensory processing in psychosis.
This problem is avoided by those whose prominent symptoms are negative, which often includes
avoidance of external stimuli through social withdrawal. However, this finding is in
contradiction to research on objective cognition, where the severity of negative rather than
positive symptoms is more closely associated with cognitive impairment (Addington, Addington,
& Maticka-Tyndale, 1991). Further research examining the mechanisms underpinning the
relationship between cognitive failures and schizophrenia may highlight a significance of
interactions between symptoms and day-to-day factors, such as stress and time of day.
Relationship between substance use and cognitive failures
Eight articles explored the impact of substance use on cognitive failures: two on nicotine, one on
alcohol, and five on cannabis, ecstasy, or polydrug use (Table 3). Of these, only the alcohol
paper studied a clinical population: patients with alcohol dependence disorder. Daily smoking
seemed to be associated with increased failures (Parrott & Kaye, 1999; Wan, Friedman, Boutros,
& Crawford, 2008), as did alcohol dependence (Manning et al., 2016). The literature on cannabis
and ecstasy did not provide clear evidence; only cannabis seemed to have a small detrimental
effect on everyday cognition (Fisk & Montgomery, 2008).
INSERT TABLE 3 ABOUT HERE.
Interestingly, none of these articles examined acute intoxication, focusing instead on functioning
during withdrawal and periods of abstinence/sobriety, and incorporating a mixture of occasional
and chronic users. It must be noted that few of these studies controlled for time since last use,
with most asking for a specific period of abstinence (e.g. 7 days since last ecstasy use) and
relying on self-report only, rather than any objective measures of compliance. Given the
20
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possibility of intraindividual variations in drug clearance rates (as in ecstasy; e.g. De La Torre et
al., 2000), the findings presented in this review should be viewed as providing only an early
indication of the patterns of real life cognition associated with substance use.
Nicotine
There has been much research conducted into the effects of nicotine on cognition, with
immediate beneficial effects after use evident even in non-users (Heishman, Kleykamp, &
Singleton, 2010). However, this review identified only two papers that looked at the subjective
experience of cognitive functioning in smokers. Daily smokers report more failures than those
who smoke occasionally (Wan et al., 2008), and specifically, smokers experience more slips
during periods of abstinence (Parrott & Kaye, 1999). Abstaining smokers also reported more
stress, lower mood, and reduced arousal, and experienced everyday life as having more hassles;
this highlights the significance of nicotine for sustaining normal functioning in users (Parrott &
Kaye, 1999). This paper also highlights the complexity concerning the nature of the relationship
between cognitive failures and substance use. Potentially there are other mediating or exclusively
contributing factors such as mood and anxiety which could fully or partially account for
cognitive failures’ association with substance use. These need to be taken alongside any
alterations in brain functioning which may be a direct results of the substance use; although it is
presumed in non-clinical samples that this would lead to elevated cognitive failures being
transitory and temporally related to substance use. In assessing the existing research, it is
important to note that both studies utilised groups with large variations in the number of
cigarettes smoked daily (e.g. range from 5-60 daily for abstaining smokers; Parrot & Kaye,
1999). Given the well-documented effects of nicotine withdrawal, such large differences in
dosage would be expected to impact upon cognition to different degrees.
21
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Nevertheless, an important issue raised in these two articles is the potential role of nicotine as a
kind of self-regulator, important for sustaining normal functioning and without which, cognition
may be impaired. Related to this, Wan et al. (2008) noted potential patterns of use of nicotine for
self-medication in schizotypal individuals, a group known to have increased emotional reactivity
(Collip et al., 2013). Alongside aiding cognition, therefore, nicotine may also play an essential
role in assisting emotion regulation in a subgroup of users, with use having an indirect impact on
cognitive failures.
Alcohol
The only article focusing on alcohol use was also the only one to study a population with a
substance use disorder (Manning et al., 2016). Individuals with alcohol dependence complain of
increased cognitive failures even after a period of detoxification. At three months follow up,
abstainers reported significant reductions in cognitive failures, whilst those who relapsed did not.
This would suggest that, at least for alcohol dependence, cognitive failures is related to the
intoxication and withdrawal associated with the substance use itself, rather than being related to
any longer lasting changes in brain structure or functioning. Implicit within this is that cognitive
failures result from alcohol dependence and are not a potential risk marker for it.
The lack of articles studying alcohol was surprising, given the extensive literature on the effects
of alcohol intoxication on cognition including executive function, inhibitory control, memory,
and motor control (Peterson, Rothfleisch, Zelazo, & Pihl, 1990; Schweizer et al., 2006). There
have also been more recent attempts to explore the impact of alcohol on cognition in more
naturalistic settings (e.g. bars; Lyvers & Tobias-Webb, 2010), however the lack of studies of
subjective perceptions of cognition is stark when compared to research around other substances.
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Cannabis, ecstasy and polydrug use
Five papers examined cannabis or ecstasy use; these proved difficult to isolate in users
(Montgomery & Fisk, 2007), and many researchers chose to include polydrug users.
Unsurprisingly, given the contrasting psychopharmacological effects of depressants and
stimulants, findings were mixed. A small sample of both ecstasy and cannabis users recruited by
Rodgers (2000) did not report any subjective impairment, but cannabis was associated with
heightened failures in another (Fisk & Montgomery, 2008). Cannabis users’ complaints about
problems with daily functioning were affirmed by their significant others, despite an absence of
demonstrable neuropsychological deficits (Fisk & Montgomery, 2008), adding weight to the
notion that neuropsychological assessments are not necessarily capturing all the information
related to real world cognitive functioning.
Chronic ecstasy users reported problems with memory specifically but did not endorse cognitive
failures in general (Heffernan et al., 2001). One study utilising highly chronic ecstasy users
(average 346.5 tablets in lifetime prior to study) did find high levels of cognitive failures, but
also acknowledged that most heavy ecstasy users are polydrug users (Montgomery & Fisk,
2007). Specifically, many people use cannabis to manage the low mood and irritability
associated with the “come down” from ecstasy (Klugman & Gruzelier, 2003); typically this
pattern of use would be most common in chronic consumers. Indeed, further analyses in the
study of chronic ecstasy users suggested cannabis as the key predictor of failures (Montgomery
& Fisk, 2007). These findings reflect the literature around objective measures of cognitive
functioning, where there are also conflicting findings as to whether ecstasy or cannabis is
actually the main source of impairment (e.g. Croft, Mackay, Mills, & Gruzelier, 2001; Klugman
& Gruzelier, 2003). In addition, there is the possibility that the combined effects of ecstasy and
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cannabis produce a cascade of neurobiological events which are particularly toxic. Further work
is needed to tease apart the interacting effects of substances, indeed, the effects of legal
substances such as alcohol and nicotine are often forgotten about in studies concerning illicit
substances.
The role of self-awareness in reporting cognitive failures was raised quite frequently in the
substance use literature. It was proposed that metacognitive deficits resulting from chronic use of
illicit substances may prevent accurate reflection on everyday performance (Rodgers, 2000).
However, informant-self correlations support that cannabis users are capable of reporting on
difficulties; the lack of association with objective cognitive outcomes suggests that the subtlety
of users’ real life cognitive problems are not detectable in the isolation and calm of lab testing
(Fisk & Montgomery, 2008).
Subjective cognitive failures versus performance on objective tasks in individuals with
psychological disorders
Several papers compared cognitive failures and objectively assessed cognitive performance in a
range of psychological disorders and patterns of substance use (n = 14). A range of objective
domains were tested for correlation with everyday cognition; with attention, executive function
and memory being predominant. In line with our previous review on the link between subjective
and objective cognition in healthy populations (Carrigan & Barkus, 2016), there were no
consistent associations evident between cognitive failures and any objective domains of
cognition. These findings are displayed in Table 4, which displays the domains examined and
whether a relationship with cognitive failures was found.
INSERT TABLE 4 ABOUT HERE
24

COGNITIVE FAILURES, PSYCHOLOGICAL DISORDERS, SUBSTANCE USE
Psychological disorders
There was a consistent disparity between neuropsychological outcomes and self-reports of daily
functioning of people with a diagnosed psychological disorder, as in healthy populations
(Carrigan & Barkus, 2016). Farrin et al. (2003) found a relationship between CFQ scores and
errors and longer reaction times in depression, however other studies of affective disorders failed
to uncover any relationship (Burdick et al., 2005; Preiss et al., 2010; Schouws et al., 2012).
Cognitive biases present in individuals with mood disorders could be argued to skew reporting in
a negative direction, however the experience of poor concentration is a well-accepted symptom
of depression (American Psychiatric Association, 2013; Watts & Sharrock, 1985). This disparity
may actually be due to problems with the ecological validity of current objective measures.
An article studying war veterans with PTSD was the only study to identify objective test parity
with cognitive failures across all domains tested, including executive function, memory and
verbal function (Koso et al., 2012). This perhaps supports the proposed mechanism behind
increased failures in PTSD, whereby intrusive memories increase slips via depletion of cognitive
resources (Boals, 2008). These findings also highlight the significance of the link between PTSD
symptoms (such as flashbacks) that are precipitated by “triggers” in daily life, and the level of
disruption to cognitive, occupational, and social function experienced by sufferers. Further
consideration of the role of situational factors in cognitive failures in psychopathology more
generally may serve to increase our understanding of this phenomenon.
Some final findings of note were produced by Donohoe et al. (2009) in their study on
schizophrenia. The authors suggested that one element of insight into illness is cognitive insight
or awareness of cognitive functioning. They suggested that the CFQ essentially provides a
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measure of cognitive insight, and so its utility lies only in identifying discrepancies between
neuropsychological performance and self-reported perceptions of the same. Predicted premorbid
IQ (as per the Wechsler Test of Adult Reading) and episodic memory were both correlated with
CFQ scores only for a few patients with intact clinical (i.e. illness) insight. That is, clinical
insight was necessary, but not sufficient, for cognitive insight.
Substance use
There was an even greater “gap” between objective and subjective cognition in substance use. As
mentioned earlier, this was proposed to be due to metacognitive deficits in drug users (Rodgers,
2000), whether due to substance use or personality factors that predispose to substance use.
Whilst correlations between subjective and objective cognition were not explored, ecstasypolydrug users had both higher CFQ ratings and poorer working memory performance than nonusers (Montgomery & Fisk, 2007), and alcohol dependent patients had increased CFQ scores as
well as memory, working memory, and executive function issues (Manning et al., 2016). More
significant cognitive problems may be expected in the clinical population of the latter study, but
the former focused on highly chronic ecstasy users, albeit without a diagnosed disorder. Perhaps
individuals only experience a noticeable severity of problems and/or unable to compensate for
them once a certain threshold of substance abuse is surpassed.
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Discussion
This review identified a range of studies on cognitive failures in different psychological
disorders. Failures in substance users were also explored, given that substance use is known to
influence objective cognitive performance, as well as being closely related to psychological
disorders.
What is the relationship between cognitive failures and psychological disorders?
There appears to be a link between a number of psychological disorders and heightened reports
of cognitive failures. Patients with depression and PTSD were consistently more prone to
everyday failures than controls, with medium to large effect sizes. Researchers in both of these
disorders posited that particular aspects of their psychopathology drain cognitive resources to
result in failures: in depression, catastrophic reactions to perceived errors (Farrin et al., 2003); in
PTSD, intrusive thoughts and flashbacks (Boals, 2008). Individuals with bipolar disorder were
the only group to report fewer cognitive failures than controls, which raised the issue of insight;
this will be discussed in detail later.
It is important to note that the existing research is largely correlational in nature. Therefore, it is
still unclear whether cognitive failures are consequent of other psychological symptoms or part
of the core symptoms present in these disorders. Consideration also needs to be given as to
whether cognitive failures are part of the inherited vulnerability for psychological disorders.
However, given the lack of disorder specificity, as well as cognitive failures’ correlation with
neuroticism in both healthy and disordered populations (van den Bosch et al., 1993; Wilhelm,
Witthöft, & Schipolowski, 2010), it is possible that cognitive failures could relate to
psychological distress or problems of emotion regulation more generally.
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What is the relationship between cognitive failures and substance use?
The picture of cognitive failures in substance use is even less clear. Nicotine seems to be
associated with cognitive failures in a dose-response fashion according to level of use, with daily
smokers experiencing more failures than non-daily smokers (Wan et al., 2008). However, the
significant factor appears to be withdrawal rather than intoxication, with abstaining smokers
suffering more daily hassles and failures than non-abstainers (Parrott & Kaye, 1999). Nicotine is
often used as an emotion regulation tool (Schleicher, Harris, Catley, & Nazir, 2010) with
deprivation reducing thresholds for coping with stress. In abstaining smokers, increased failures
may therefore occur alongside or as a kind of cognitive consequence of stress.
Surprisingly, there was only one article identified that considered alcohol use; this focused on a
clinically dependent population and found CFQ scores were still heightened immediately postdetox, but were reduced after three months in those who continued to abstain (Manning et al.,
2016). Patients who relapsed did not experience the same reduction in cognitive failures,
suggesting that time since alcohol dependence is perhaps more important than brain changes
associated with abuse for everyday cognitive functioning. To highlight the limited research on
self-reported everyday cognition and alcohol, we excluded only one alcohol article on the basis
that it utilised a different measure of subjectively-perceived cognition (Ling et al., 2003). This
paper found that level of alcohol consumption in a non-clinical sample correlated with level of
everyday memory problems, with heavy drinkers reporting more issues than moderate drinkers,
and moderate drinkers more than abstainers. These papers suggest, similarly to nicotine, that
potentially it may be the withdrawal state which is potent to predisposing to cognitive failures.
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Long term heavy cannabis use appears to be linked to increased vulnerability to failures to a
greater extent than ecstasy (Fisk & Montgomery, 2008; Montgomery & Fisk, 2007). Findings
were overall limited, inconsistent, and complicated by polydrug use.
Existing papers, whilst limited, suggest substance use has the potential to increase cognitive
failures. As such, substance use needs further consideration as an issue affecting measurement in
further research into everyday cognition in clinical and non-clinical populations.
How do subjective cognitive failures relate to performance on objective tasks in people with
psychological disorders or in substance users?
There was no evidence of a definitive link between objective neuropsychological outcomes and
self-reported cognitive failures in either psychological disorders or substance use. Comparison
between these two approaches to measuring cognition represents a key topic of interest, and
contributes to the ongoing debate regarding self-awareness, reliability, and validity of subjective
reports of cognition. Some authors suggest reported failures in the absence of
neuropsychological deficits were an indication of impaired self-awareness related to illness (as in
schizophrenia; e.g. Donohoe et al., 2009). This mirrors the debate around neuroticism, where
increased self-reported failures are viewed as reflecting tendency for negative self-evaluation.
Poor self-awareness is not necessarily indicated by a lack of relationship between objective and
subjective cognitive measures. Rather, everyday cognitive failures may tap into aspects of
cognition quite different to those accessed in the lab. If affective dysregulation is indeed a
significant contributor to vulnerability for cognitive failures, then real world stressors both
external and internal are likely to trigger errors for psychologically vulnerable individuals. This
would occur regardless of one’s level of objective neuropsychological ability, hence the low
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correlation between lab-based and real world performance. The current findings highlight the
need to develop more ecologically valid measures of cognition, particularly ones that can capture
real world emotional factors more readily.
Limitations
An earlier goal of this review was to elucidate distinct profiles of real life cognitive functioning
for specific psychological disorders. However, the literature search revealed that this would not
be possible. The number of studies for each disorder was limited; some disorders were the focus
in as few as one or two articles, and others were not studied at all. The lack of studies was
surprising, given the wide acceptance as “common knowledge” (as well as being acknowledged
in the DSM 5) that mild cognitive issues often go hand-in-hand with psychological disorders.
Similarly, we were able to identify only a handful of articles exploring the link between CFQ
scores and substance use. Most notably missing were papers regarding alcohol use, given its
global popularity and legality.
Ideally, a PRISMA review would also include an analysis of the quality of articles. However,
this was not possible. This area of research is relatively small, and the necessarily broad scope of
the search meant that articles were primarily correlational, using a variety of populations and
methods; this makes comparisons using one set of criteria difficult. In addition, there remain
inconsistencies in how cognitive failures are conceptualised. As such, it is important to qualify
conclusions of the current review as tentative and preliminary.
There are a few broad limitations identified which form recommendations for future research. In
particular, phase of illness for clinical populations was not always considered. Both cognitive
functioning and perceptions of functioning may shift over time. For example, individuals in
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prodromal stages of illness are likely to report increased cognitive problems (e.g. as in psychosis;
Schultze-Lutter, Klosterkötter, & Ruhrmann, 2014), which may reflect acute awareness of
decline in their functioning. The sense of there being “something wrong” may in itself ensure
subjective monitoring is heightened. Chronic sufferers, by contrast, may have a different profile
of failures; perhaps due to improvements in cognition related to medication, stabilisation of
symptoms, development of compensatory strategies, or the lowering of expectations of their own
capacities. Additionally, further studies into clinical populations would benefit from
consideration of substance use, and attendance to the pharmacodynamics of the substances
concerned.
Clinical implications
Despite the limitations of this review, the current findings highlight important implications for
clinical practice. First, previous findings in healthy populations that negative affect and
psychological distress increase cognitive failures can now be extended. Psychological distress
seems to impact day-to-day cognitive functioning proportionately, such that individuals at the
extremes of the distress continuum, (i.e. those with clinical disorders) report significantly higher
levels of failures than those with subclinical levels of distress. Currently, the extent to which
subtle cognitive deficits are considered by clinicians is limited (Burdick et al., 2005). A brief,
self-report tool such as the CFQ could be introduced at the assessment stage in addition to
neuropsychological measures in order to better inform clinicians of the particular struggles faced
by patients. Similarly, cognitive failures could be used to monitor shifts in perceived daily
functioning during treatment. Cognitive behavioural therapies could be designed to address
cognitive failures directly; normalising the experience of mistakes, helping clients to identify and
mediate the effects of triggers for slips and failures such as stress.
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Conclusions and future directions
It has previously been suggested that cognitive failures reflect both trait vulnerabilities and the
influence of fluctuating state factors (Carrigan & Barkus, 2016). We can now add to this that a
range of psychological disorders including depression, anxiety, PTSD, and schizophrenia are all
associated with increased self-reported failures in everyday life. In addition, use or withdrawal
from substances including nicotine, alcohol, and cannabis may also lead to heightened failures,
particularly in those whose pattern of use is chronic. Self-reported cognitive failures do not
correlate with objective measures of cognition in either clinical or substance use populations,
suggesting they may measure unique aspects of cognition.
The next step in this area of research will be to determine whether some common factor is
responsible for heightened cognitive failures across both clinical and non-clinical individuals.
For example, we already know that cognitive failures are associated with negative affect and
neuroticism in healthy populations; one possibility is that emotional dysregulation increases
vulnerability to slips. Another important aspect of further research into cognitive failures will be
attempts to resolve the ongoing debate around the validity of self-reports, specifically with
regards to the role of personality traits that may impact the accuracy of self-perceptions, such as
neuroticism.
Although this review has focused on simple, retrospective self-reports, there are some new
approaches to measurement of subjectively-perceived cognitive failures which will likely be of
value in answering some of these remaining questions. A methodology of particular interest is
ambulatory assessment, also known as experience sampling (e.g. Myin-Germeys, Delespaul, &
van Os, 2003). This involves capturing self-reports of errors in vivo; failures are reported as they
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occur during everyday activities, removing memory bias. Another major benefit of the use of
experience sampling is the possibility for studying changes in functioning at multiple time points
throughout each day. This would allow for examination of fluctuations, and the factors which
may interact with trait and illness-related vulnerability to shape these shifts, such as time of day,
stressors, and substance use. To date, only a handful of studies have utilised experience sampling
to study cognitive failures in healthy populations (Kane et al., 2007; Lange & Süß, 2014;
McVay, Kane, & Kwapil, 2009; Neupert et al., 2008). This approach would seem to be the next
step towards studying real world cognitive capacity in an ecologically valid way, but as it is not
yet widespread, retrospective self-reports as captured via measures such as the CFQ remain
invaluable in providing a picture of cognition as it translates into everyday life.
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Table 1
Associations Between Affective Disorders and Cognitive Failures.
Reference

Study population

Findings

Group differences: pvalue; Cohen’s d [95% CI]

Affective disorders
MacQueen,

40 patients with past or current

Patients reported more cognitive failures, and this

Clinical vs. control: p <.001;

Galway, Hay,

major depressive disorder

predicted poorer memory performance

1.77 [1.25, 2.28]****

Young, &

(SCID for DSM-IV).

independent of mood. There was no difference in

Joffe (2002)

Mean age 36.2 years; 30 males.

failures reported by symptomatic versus improved
patients (i.e. antidepressant non-responders versus
responders).

Farrin, Hull,

43 UK military servicemen with

Depressed men performed worse on an attention

Clinical vs. control: p <

Unwin, &

mild depression (BDI > 10).

task and also reported higher CFQ scores than

.0001; 1.57 [1.13, 2.02]****

Wykes (2003)

Mean age 35.79 years.

non-depressed men.

Burdick,

37 outpatients with bipolar I or

75% of patients displayed mild

CFQ – depression

Endick, &

II in various phases of illness

neuropsychological impairment, but self-reported

relationshipa: p =.06; 0.67**
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Goldberg

(SCID for DSM-IV).

cognitive failures did not correlate significantly

CFQ – mania relationshipa:

(2005)

Mean age 46.2 years; 20 males.

with measures of mood or objective outcomes.

p = .09; - 0.59**

Sullivan &

26 individuals with seasonal

Both patient groups reported greater experiences

MDD vs. control:

Payne (2007)

depression, 8 with major

of cognitive failures than healthy individuals.

p <.001; 1.68 [0.89,

depressive disorder (Seasonal

There was no difference between the two

2.47]****

Pattern Assessment

depression subtypes.

MDD vs. SAD:

Questionnaire > 11; BDI-II

p >.05; 0.56 [-0.24, 1.37]**

>17).

SAD vs. control:

Age 18-22 years; 4 males.

p <.001; 1.12 [0.63, 1.61]***

Preiss,

32 outpatients with depression,

Found no differences in attentional networks in

Did not report on group

Kramska,

currently in euthymic stage

euthymic patients compared with controls.

differences or relationship

Dockalova,

(MINI).

Attentional performance did not correlate with

between CFQ and diagnostic

Holubova, &

Mean age 46.8 years; 12 males.

CFQ scores. Group comparisons for CFQ scores

measures.

Kucerova

were not reported.

(2010)
Schouws,

101 elderly patients with

Patients reported no greater failures than controls

Clinical vs. control: p =
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Comijs, Stek,

bipolar, currently in euthymic

despite exhibiting impairment in several objective

& Beekman

stage (SCID for DSM-IV).

domains. Patients with worse objective

(2012)

Mean age 69.3 years; 50 males.

performance reported fewer cognitive failures than

0.36; 0.14 [-0.02, 0.04]

those with better performance.
p values for some studies were not reported and thus are not included in the table.1 = r coefficients transformed into Cohen’s d; CIs
not calculated. Classification of effect sizes: trivial (Cohen's d ≤ .2); * small (Cohen's d > .2); ** moderate (Cohen's d > .5); *** large
(Cohen's d > .8); **** very large (Cohen's d > 1.3).
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Table 2
Associations Between Non-Affective Disorders and Cognitive Failures.
Reference

Study population

Findings

Group differences: pvalue; Cohen’s d [95% CI]

Anxiety disorders
Merckelbach,

3 studies including 30 females

CFQ scores were correlated with general

Spider phobic vs. control:

Muris,

with spider phobias and 224

psychopathological symptom severity. Clinically

-0.01 [-0.51, -0.49]

Nijman, & de

outpatients with anxiety (panic

anxious individuals and those with OCD reported

Anxiety vs. control:

Jong (1996)

disorder, GAD, social phobia,

fewer failures than healthy controls, whilst

-0.39 [-0.64, -0.14]*

OCD, atypical anxiety) or

clinically depressed individuals reported more

Depressed vs. control:

depression (SCID for DSM-III-

than controls. Individuals with a phobia did not

0.91 [0.43, 1.41]***

R).

differ to controls in their CFQ scores.

OCD vs. control: -0.3 [-0.68,

Mean age 31 years; 30 females

0.08]*

only – mean age 35 years; 105
males.
Grisham,

23 patients with compulsive

Patients reported more cognitive failures than

Hoarding vs. clinical
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Norberg,

hoarding patterns and 17 non-

healthy controls, but there were no differences

controls:

Williams,

hoarding patients with current

between hoarding and non-hoarding patients.

p > .05; 0.2 [-0.45, 0.86]*

Certoma, &

anxiety (GAD, social phobia,

Hoarding vs. non-clinical

Kadib (2010)

OCD, panic disorder, specific

control:

phobia, PTSD) or mood

p <.01; 1.06 [0.39, 1.73]***

disorders (ADIS for DSM-IV).
Mean age 49 years; sex of
clinical groups not reported.
Post-traumatic stress disorder
Boals (2008)

13 Holocaust survivors (no

Intrusive thoughts (i.e. Holocaust-related PTSD

CFQ - PTSD symptom

diagnostic measures; assumed to

symptoms) predicted the frequency of everyday

relationship1: p <.05;

evidence PTSD symptoms as

failures.

1.46****

per previous findings with this
population).
Mean age 72 years; 13 males
only.
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Boals & Banks 909 undergraduate students who

PTSD symptoms were related to cognitive

CFQ-PTSD symptom

(2012)

had experienced a traumatic

failures, and an interaction with perceived stress

relationship1: p <.001;

event (PCL-S > 43 and DSM-

had an additive effect on cognitive failures.

0.63**

Severity of PTSD symptoms was related to both

Clinical vs. control:

Hadzihalilovic, (DSM-IV criteria).

objective cognitive impairment and increased

p < .001; 3.83 [3.09, 4.86]

& Hansen

Mean age 44 years; 45 males

CFQ scores.

****

(2012)

only.

IV-TR criteria).
Mean age not reported; 319
males.
Koso, Sarač-

45 adult male ex-servicemen

Schizophrenia
van den

24 patients with schizophrenia

All psychiatric patient groups experienced higher

Schizophrenia vs. MDD:

Bosch,

and 13 patients with depression

levels of cognitive failures than normal

-0.25 [-0.93, 0.42]*

Rombouts, &

(DSM-III-R criteria).

individuals, and these ratings were consistent over

Schizophrenia vs. controls:

van Asma

Mean age schizophrenia 28.7

a 3-month period. Symptoms relating to anxiety

1.2 [0.56, 1.84]***

(1993)

years; mean age depression 39.9

and depression were found to be most closely

MDD vs. controls:
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years; sex of clinical groups not

associated with everyday failures.

1.72 [0.91, 2.53]****

reported.
Donohoe et al.

51 stabilised patients with

Patients did not report more cognitive failures than Clinical vs. controls:

(2009)

chronic schizophrenia (SCID for

controls. Cognitive failures and objective

p not reported; 0.33 [-0.06,

DSM-IV).

neuropsychological assessment correlated only for

0.71]*

Mean age 39.8 years; 20 males.

some patients with good clinical insight (i.e. good
awareness of illness). Overall, clinical insight and
cognitive insight (cognitive failures correlate with
objective outcome) not linked.

p values for some studies were not reported and thus are not included in the table.1 = r coefficients transformed into Cohen’s d; CIs
not calculated. Classification of effect sizes: trivial (Cohen's d ≤ .2); * small (Cohen's d > .2); ** moderate (Cohen's d > .5); *** large
(Cohen's d > .8); **** very large (Cohen's d > 1.3).
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Table 3
Associations Between Substance Use and Cognitive Failures.
Reference

Study population

Findings

Group differences: pvalue; Cohen’s d [95% CI]
Nicotine

Parrott & Kaye

25 each of smokers (mean

Abstaining smokers reported greater stress, lower

Smokers vs. non-smokers:

(1999)

age 24.3 years; 15 male),

arousal, less pleasure, and more cognitive failures

0.40 [-0.16, 0.96] *

abstaining smokers (mean

than both non-smokers and non-abstaining

Abstaining vs. smokers:

age 23.5 years; 11 male),

smokers. There were no differences between these

0.89 [0.31, 1.47] ***

and non-smokers (mean

latter groups.

Abstaining vs. non-smokers:

age 26.5; 7 male).

1.29 [0.68, 1.90] ***

Wan, Friedman,

440 non-smokers (170

Daily smokers reported greater frequencies of

Daily vs. non-daily:

Boutros, &

males), 107 daily smokers

cognitive slips, and non-daily smokers reported

-0.02 [-0.42, 0.37]

Crawford (2008)

(43 males), and 47 non-

more slips in memory than non-smokers.

Daily vs. non-smokers:

daily smokers (18 males).

0.31 [0.08., 0.54] *

Overall mean age 19.01

Non-daily vs. non-smokers:
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years.

0.33 [-0.02, 0.68] *
Alcohol

Manning, Teo, Guo,

30 post-detox alcohol-

Alcohol dependence diagnosis post-inpatient

Not calculable from

Wong, & Li (2016)

dependent patients (DSM-

detoxification was associated with increased CFQ

provided data.

IV-TR criteria).

scores relative to controls.

Mean age 49.5 years; 30
male only.
Cannabis, ecstasy and polydrug use
Rodgers (2000)

15 ecstasy users (mean age Verbal memory deficits were identified in both

Ecstasy vs. cannabis:

31.4 years; 7 males), 15

ecstasy and cannabis users, whilst only ecstasy

p > .05; 0.54 [-0.19, 1.27] **

cannabis users (mean age

users exhibited impaired delayed memory.

Ecstasy vs. control:

30.25 years; 7 males).

Subjective impairment did not significantly differ

p > .05; 0.01 [-0.71, 0.72]

between groups.

Cannabis vs. control:
p > .05; -0.53 [-1.25, 0.20]
**

Heffernan, Jarvis,

3 studies comprising 91

Ecstasy users reported more errors in prospective

Same data as above study.
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Rodgers, Scholey, &

regular ecstasy users.

memory in everyday life than controls; this

Ling (2001)

Mean age 26.6 years; 52

matched with objective performance. This was not

males.

generalizable to all aspects of everyday cognition,
with no differences in ratings on the CFQ.

Montgomery & Fisk

43 ecstasy/polydrug users.

Ecstasy/polydrug users exhibited greater

Ecstasy/polydrug vs.

(2007)

Mean age 21.56 years; 24

subjective (also supported by informant) and

controls:

males.

objective deficits than non-users; however

p not reported; 0.51 [0.12,

cannabis was found to be the drug most closely

0.91] **

linked to users’ everyday problems.
Fisk & Montgomery

46 cannabis-only users.

Relative impairment in real-world memory

Cannabis vs. control:

(2008)

Mean age 21 years; sex

functioning was identified in cannabis users,

p = .02; 0.59 [0.08, 1.13] **

not reported.

although this was not found in objective measures
of executive processes. Significant others also
observed more failures in users than non-users.

Hadjiefthyvoulou,

42 ecstasy/polydrug users.

Regular illicit drug use was associated with

Ecstasy/polydrug vs.

Fisk, Montgomery,

Mean age 21.67 years; 14

deficits in objective and subjective prospective

control:
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& Bridges (2011)

males.

memory, but not cognitive failures more

p > .05; 0.25 [-0.22, 0.72] *

generally. Cognitive failures correlated with
recency of ecstasy use.
p values for some studies were not reported and thus are not included in the table. Classification of effect sizes: trivial (Cohen's d ≤
.2); * small (Cohen's d > .2); ** moderate (Cohen's d > .5); *** large (Cohen's d > .8); **** very large (Cohen's d > 1.3).
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Table 4
Comparison of Objective Cognitive Assessment and Subjective Cognitive Failures in Psychological Disorders and Substance Use.
Psychological disorders
Reference

Disorder

Overall

Attention

cognition

MacQueen, Galway, Hay, Young, &

Executive

Memory

function

Depression

Working

Verbal

memory

function

X

Joffe (2002)
Farrin, Hull, Unwin, & Wykes (2003)

Depression

√

Preiss, Kramska, Dockalova, Holubova,

Depression

X

Bipolar

X

X

X

Bipolar (elderly)

X

√

X

X

√

√

& Kucerova (2010)
Burdick, Endick, & Goldberg (2005)1
Schouws, Comijs, Stek, &
Beekman (2012)
Grisham, Norberg, Williams, Certoma,
& Kadib (2010)
Koso, Sarač-Hadzihalilovic, & Hansen

Compulsive hoarding

X

X

patterns
PTSD

√
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(2012)
Donohoe et al. (2009)
Reference

Schizophrenia

X

√*

Type of substance

Overall

Attention

use

Executive

cognition

function

X

√

√*

X

Memory

Working

Verbal

memory

function

Substance use
Manning, Teo, Guo, Wong, & Li (2016)
Fisk & Montgomery (2008)

Alcohol
Cannabis use

Parrott & Kaye (1999)

Ecstasy use

Heffernan, Jarvis, Rodgers, Scholey, &

Ecstasy use

√

√

X
X

X

X

Ling (2001)
Montgomery & Fisk (2007)

Ecstasy-polydrug use

Hadjiefthyvoulou, Fisk, Montgomery, &

Ecstasy-polydrug use

X

√

X
X

Bridges (2011)
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Notes: √ Denotes domain compared with CFQ scores and association identified. X Denotes domain compared with CFQ scores but no
association identified. Columns left blank donate domains of cognition not studied by the cited article. *Parity only met for patients
with intact clinical insight.
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Figure captions
Figure 1. Flow diagram of study selection for systematic review of published research on
cognitive failures in populations with psychological disorders.
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